FARCO-PHARMA, a Klosterfrau Healthcare Group company, is acquiring Purenum GmbH, which was founded in 2017. The company, which produces gels as well as instillation solutions for urological use, will expand its range with the certified medical product of Purenum GmbH, mediNiK^®. This will now enable effective and efficient marketing of the gel to facilitate the endoscopic removal of kidney stone fragments.

From September 2014 to March 2023, the research team was supported by the BMBF's GO-Bio funding programme. This made it possible to develop a demonstrator of the adhesive. In December 2017, biologist Ingo Grunwald, PhD, and engineer Manfred Peschka founded the spin-off company Purenum GmbH to bring the adhesive to market.

The Bremen-based founding team of Ingo Grunwald and Manfred Peschka will continue to work in research and development in the new constellation after the successful takeover.

About mediNiK^®

Kidney stones are often removed by endoscopic surgery. If a stone is too large, the urologists break it up with a laser. The larger fragments can be removed with a gripper, but the smaller fragments cannot. They remain in the kidney in the hope that they will go away naturally. In the future, doctors will be able to actively remove even the smallest stone remnants from the kidney during the endoscopy with the hydrogel mediNiK^®.

mediNiK^® works in such a way that the two components of the hydrogel are applied one after the other via the catheter, which is inserted into the working channel of the endoscope. In the first step, the blue component of mediNiK^® surrounds the stone gravel. In the second step, the yellow component of the gel is added, forming a soft, cohesive gel that holds the stone residue together inside it. It is so stable that it can be grasped by means of a gripping instrument, followed by the complete removal of the kidney stone fragments.